Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMID 8369318)

Published in J Heart Lung Transplant on October 14, 1993

Authors

R C Bourge1, D C Naftel, M R Costanzo-Nordin, J K Kirklin, J B Young, S H Kubo, M T Olivari, E K Kasper

Author Affiliations

1: Transplant Cardiologists Research Database Center, University of Alabama, Birmingham 35294.

Articles citing this

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to left heart disease. Ann Thorac Med (2014) 1.39

Intrathoracic organ transplantation in the United Kingdom 1995-99: results from the UK cardiothoracic transplant audit. Heart (2002) 1.02

Management of acute severe perioperative failure of cardiac allografts: a single-centre experience with a review of the literature. Can J Cardiol (2007) 0.97

Primary graft failure after heart transplantation. J Transplant (2011) 0.93

Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart Transplantation. J Transplant (2010) 0.81

New developments in the diagnosis and management of cardiac allograft vasculopathy. Tex Heart Inst J (1995) 0.80

Impact of current management practices on early and late death in more than 500 consecutive cardiac transplant recipients. Ann Surg (2000) 0.80

Donor selection in heart transplantation. J Thorac Dis (2014) 0.79

Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition. Transplantation (2015) 0.78

Right ventricular stroke work index as a negative predictor of mortality and initial hospital stay after lung transplantation. J Heart Lung Transplant (2013) 0.77

First-year clinical outcomes in gender-mismatched heart transplant recipients. J Cardiovasc Nurs (2012) 0.77

Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation. Drug Des Devel Ther (2016) 0.77

Theodore E. Woodward Award: Coming in out of the rain. Relieving congestion in heart failure. Trans Am Clin Climatol Assoc (2009) 0.76

Effect of bosentan on pulmonary hypertension secondary to systolic heart failure. Pharmacology (2013) 0.75

Who gets a heart? Rationing and rationalizing in heart transplantation. West J Med (1997) 0.75

Lowering Pulmonary Wedge Pressure after Heart Transplant: Pulmonary Compliance and Resistance Effect. Arq Bras Cardiol (2015) 0.75

Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection. J Cardiothorac Surg (2017) 0.75

Mortality, rehospitalization, and post-transplant complications in gender-mismatched heart transplant recipients. Heart Lung (2017) 0.75

[Evaluation of the potential organ donor with special regards to heart donation]. Wien Klin Wochenschr (2010) 0.75

Articles by these authors

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med (1993) 7.19

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med (1984) 6.74

Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med (2000) 6.27

Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. Am J Med (1979) 4.36

Anthracycline-induced cardiotoxicity. Ann Intern Med (1996) 4.31

Replacement of the aortic root in patients with Marfan's syndrome. N Engl J Med (1999) 4.17

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation (1996) 4.01

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med (1990) 3.88

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation (1990) 3.72

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med (2000) 3.70

A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation (1981) 3.49

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol (1996) 3.47

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation (2001) 3.15

Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes (1981) 2.89

Negative influences of ascites on the cardiac function of cirrhotic patients. Am J Med (1975) 2.57

Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation (1997) 2.53

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol (1993) 2.49

Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol (1999) 2.36

Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg (1983) 2.29

Team management of patients with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association. Circulation (2000) 2.22

Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation? J Thorac Cardiovasc Surg (2001) 2.22

Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med (1985) 2.22

Acute cardiac events temporally related to cocaine abuse. N Engl J Med (1986) 2.18

Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol (1989) 2.17

Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol (1993) 2.15

Giant cell myocarditis: first report of disease recurrence in the transplanted heart. J Heart Lung Transplant (1992) 2.15

High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation (2001) 2.13

Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol (2000) 2.12

Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation (1979) 2.11

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation (1996) 2.10

Outcome after a "perfect" Fontan operation. Circulation (1990) 2.06

Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation (2000) 2.04

Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med (1978) 2.04

Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther (1977) 2.03

Legionella birminghamensis sp. nov. isolated from a cardiac transplant recipient. J Clin Microbiol (1987) 1.94

Complications of endomyocardial biopsy in heart transplant patients. J Heart Lung Transplant (1993) 1.92

Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption. Circulation (1999) 1.88

Effects of glucocorticoids on energy metabolism and food intake in humans. Am J Physiol (1996) 1.86

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest (1986) 1.84

Surgery for acute dissection of ascending aorta. Should the arch be included? J Thorac Cardiovasc Surg (1992) 1.83

Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg (1997) 1.78

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J (1999) 1.76

Suppression of sympathetic nervous system during fasting. Science (1977) 1.71

Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation (1996) 1.71

The neurohumoral axis in congestive heart failure. Ann Intern Med (1984) 1.66

A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med (1989) 1.64

Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg (1999) 1.63

Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients. Am J Surg Pathol (1994) 1.58

A general population survey of rest cramps. Age Ageing (1994) 1.57

Device-based change in left ventricular shape: a new concept for the treatment of dilated cardiomyopathy. J Thorac Cardiovasc Surg (2001) 1.56

Myocarditis confirmed by biopsy presenting as acute myocardial infarction. Br Heart J (1985) 1.56

Effect of diet and cold exposure on norepinephrine turnover in brown adipose tissue of the rat. J Clin Invest (1982) 1.56

Hypoplastic left heart syndrome: experience with palliative surgery. Am J Cardiol (1980) 1.55

Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients. JAMA (1988) 1.55

Results of partial left ventriculectomy for dilated cardiomyopathy: hemodynamic, clinical and echocardiographic observations. J Am Coll Cardiol (2000) 1.55

Pretransplantation risk factors for death after heart transplantation: the Henri Mondor experience. J Heart Lung Transplant (1998) 1.53

Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor: results of a 1 year multicentre feasibility study. Eur Heart J (2001) 1.53

Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail (1995) 1.52

B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am Heart J (2005) 1.51

Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol (1992) 1.50

Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med (1987) 1.49

Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol (1993) 1.49

Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant (1998) 1.46

Assessment of pulsed Doppler echocardiography in detection and quantification of aortic and mitral regurgitation. Br Heart J (1980) 1.44

Catecholamine modulation of rapid potassium shifts during exercise. N Engl J Med (1985) 1.43

Evidence for functional sympathetic reinnervation of left ventricle and coronary arteries after orthotopic cardiac transplantation in humans. Circulation (1995) 1.42

One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg (1998) 1.42

Early recurrence of chronic active myocarditis after heart transplantation. Hum Pathol (1994) 1.41

Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA (1989) 1.40

Relationship of urinary serotonin excretion to cigarette smoking and respiratory symptoms. The Normative Aging Study. Chest (1992) 1.40

Intermediate septal accessory pathways: electrocardiographic characteristics, electrophysiologic observations and their surgical implications. J Am Coll Cardiol (1991) 1.40

Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease. Am J Med (2000) 1.39

Attenuation of waiting time mortality with heterotopic heart transplantation. Ann Thorac Surg (1992) 1.39

Infective discitis as an uncommon but important cause of back pain in older people. Age Ageing (2000) 1.39

Determinants of heart-lung transplantation outcomes: results of a consensus survey. Ann Thorac Surg (1993) 1.39

Factors influencing the development of hypercholesterolemia after cardiac transplantation. Am J Cardiol (1992) 1.39

Sample size requirements for evaluating heart valves with constant risk events. J Heart Valve Dis (1994) 1.38

Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest (1994) 1.38

Christiaan Barnard's contribution to the surgical treatment of Ebstein's malformation. 1963. Ann Thorac Surg (1991) 1.38

Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc Natl Acad Sci U S A (1992) 1.36

The neglected hospital wheelchair. Br Med J (Clin Res Ed) (1985) 1.36

The Fontan operation. Ventricular hypertrophy, age, and date of operation as risk factors. J Thorac Cardiovasc Surg (1986) 1.35

A prospective algorithm for the management of air leaks after pulmonary resection. Ann Thorac Surg (1998) 1.34

Contribution of collagen, elastin, and smooth muscle to in vivo human brachial artery wall stress and elastic modulus. Circulation (1996) 1.33

Stimulation of the sympathetic nervous system during sucrose feeding. Nature (1977) 1.32

Reduced sympathetic nervous system responsivity associated with the relaxation response. Science (1982) 1.31

Evidence for structural sympathetic reinnervation after orthotopic cardiac transplantation in humans. Circulation (1991) 1.30

Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J (2000) 1.29

Short- and long-term efficacy of a calcium-antagonistic agent (nifedipine) combined with methyldopa in the treatment of severe hypertension. Circulation (1980) 1.28

Value and safety of cardiac catheterization during active infective endocarditis. Am J Cardiol (1979) 1.28

Effect of diet and cold exposure on norepinephrine turnover in pancreas and liver. Am J Physiol (1979) 1.27

Acute cocaine poisoning. Importance of treating seizures and acidosis. Am J Med (1983) 1.26

Activation of the complement system by recombinant tissue plasminogen activator. J Am Coll Cardiol (1987) 1.25

The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore) (1999) 1.25

Usefulness of transesophageal echocardiography in assessment of aortic dissection. Circulation (1991) 1.22

Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol (1985) 1.19

A prospective study of the seroprevalence of Borrelia burgdorferi infection in patients with severe heart failure. Am J Cardiol (1995) 1.18